Print
Email
Print Edition StoriesThursday, November 13, 2008
Zoll closes fiscal ’08 with record numbers and a new partner
By Mass High Tech Staff
Rodney Brown on NECN: Hacking into medical devices
Resuscitation technology company Zoll Medical Corp. reports it has closed its fiscal 2008 with a 29 percent jump in revenue and 41 percent increase in profit. In addition the Chelmsford-based company has entered into a deal with California company to integrate its technology into Zoll’s E-Series defibrillators.
For the fiscal year 2008, which closed on Sept. 28, Zoll (Nasdaq: ZOLL) posted revenue of $398 million, versus 2007 revenues of $309.5 million, and a fiscal 2008 profit of $23.4 million, against $16.66 million in fiscal 2007.
According to officials at Zoll, the company’s biggest jump in sales revenue came from the North American hospital market, which increased 37 percent to $117.1 million, versus fiscal 2007 revenue of $85.3 million.
Richard A. Packer, CEO of Zoll, said that in addition to strong North American sales, international sales exceeded the company’s original estimates.
Zoll’s newest partnership is with Masimo Corp. (Nasdaq: MASI), which is working with Zoll on a multi-year technology agreement to integrate its Rainbow SET technology into Zoll’s E-Series defibrillators, which would allow them to continuously measure carbon monoxide (SpCO) and methemoglobin (SpMet) levels in the blood.
According to the companies, Masimo’s Rainbow SET technology works non-invasively, making it easier to diagnose and treat carbon monoxide poisoning and methemoglobinemia. No financial details of the agreement were disclosed.
Masimo, founded in 1989, is based in Irvine, Calif.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
